Diabetes and Anxiety: Causes, Symptoms, and Prevention

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Generalized anxiety disorder affects an estimated 14 to 40 percent of people with diabetes — much higher than in the general population.
  • Fear of hypoglycemia is a distinct, common, and modifiable anxiety pattern that often leads to chronically elevated glucose targets and avoidance of insulin.
  • Hypoglycemia mimics anxiety physically — tremor, palpitations, sweating, dizziness — so distinguishing low blood sugar from a panic attack is critical.
  • The GAD-7 is the standard 7-item anxiety screening tool, with a score of 10 or higher suggesting moderate to severe anxiety.
  • SSRIs, CBT, exposure therapy for needle phobia, and continuous glucose monitoring (CGM) for hypoglycemia fear are first-line treatments — benzodiazepines are usually avoided long term.

Anxiety disorders affect 14 to 40 percent of people with diabetes, depending on the population and the tool used. Beyond generalized anxiety, diabetes-specific patterns include fear of hypoglycemia, needle phobia, social anxiety around dosing and meals, and health anxiety about complications. Hypoglycemia produces physical symptoms that mimic anxiety attacks, making accurate self-recognition essential. SSRIs, cognitive behavioral therapy, exposure therapy, and continuous glucose monitoring are the most useful evidence-based interventions.

How Common Is Anxiety in Diabetes?

Anxiety Pattern Approximate Prevalence in Diabetes
Generalized anxiety disorder 14 to 20 percent
Subclinical/elevated anxiety symptoms 30 to 40 percent
Fear of hypoglycemia (clinically significant) 20 to 30 percent (higher in insulin users)
Needle/injection phobia 10 to 14 percent
Panic disorder 3 to 4 percent (vs ~2% general adult)

Anxiety often coexists with depression — see the companion guide on diabetes and depression.

Diabetes-Specific Anxiety Patterns

Fear of Hypoglycemia (FOH)

  • Develops after one or more severe lows — especially nocturnal lows or lows that caused loss of consciousness or required help
  • Common consequences: keeping glucose above target (“running high”), reducing or skipping insulin, preventive snacking, avoiding exercise, avoiding driving, sleeping with the light on or with a partner monitoring
  • Paradoxically increases A1C and microvascular complication risk
  • CGM reduces FOH substantially in many studies — the data resolves uncertainty

Needle and Injection Phobia

  • Most common in newly diagnosed type 1 diabetes or new insulin starts in type 2
  • Can also affect fingerstick checks, CGM insertion, or vaccinations
  • Physiologic vasovagal response (faint, pallor, nausea) plus avoidance behavior
  • Treated with graded exposure, distraction techniques, smaller needles, injection ports, and sometimes pre-procedural anxiolytic

Health Anxiety About Complications

  • Persistent worry about kidneys, eyes, feet, heart, or sexual function
  • May lead to excessive monitoring or, conversely, avoidance of appointments
  • Reassurance-seeking can become a maintaining factor
  • CBT specifically targets the maintaining behaviors

Social Anxiety Around Diabetes Tasks

  • Discomfort dosing insulin, checking glucose, or eating differently in public
  • Worry about visible CGMs or pumps
  • May cause underdosing or skipped meals in social settings

Symptoms of Generalized Anxiety

Cognitive and Emotional

  • Persistent worry that is hard to control
  • Anticipation of the worst case in many situations
  • Difficulty concentrating; mind goes blank
  • Irritability
  • Feeling on edge or restless

Physical

  • Muscle tension (jaw, neck, shoulders)
  • Sleep disturbance — difficulty falling asleep or staying asleep
  • Fatigue from poor sleep and constant vigilance
  • Headaches
  • Gastrointestinal symptoms (nausea, diarrhea, IBS overlap)
  • Tremor, palpitations, sweating (especially in panic episodes)

The Glucose-Anxiety Crossover

Hypoglycemia and anxiety produce nearly identical physical symptoms because both activate the sympathetic nervous system.

Symptom Hypoglycemia Anxiety/Panic
Tremor Yes Yes
Sweating Yes Yes
Palpitations Yes Yes
Dizziness Yes Yes
Hunger Yes Sometimes
Confusion / cognitive slowing Yes (severe lows) Less common
Sense of impending doom Sometimes Common in panic
Resolution Glucose 60+ min after eating carbs 10 to 30 minutes with calming or distraction

The single most useful action when these symptoms occur is to check glucose first. For people on insulin or sulfonylureas, this is especially important — see related discussion in our piece on hypoglycemia unawareness.

Screening

  • GAD-7. Seven items, scored 0 to 3 each (0 to 21 total). Cutoffs: 5 mild, 10 moderate, 15 severe. Validated across many languages and clinical settings.
  • GAD-2. First two items for rapid screening; positive screen prompts the full GAD-7.
  • Hypoglycemia Fear Survey-II (HFS-II). Specific to fear of hypoglycemia.
  • Diabetes Distress Scale. Captures the diabetes-specific distress that often coexists with anxiety.

The ADA recommends screening for psychosocial issues at diagnosis, periodically thereafter, and at transitions in care.

Treatment Options

Psychotherapy

  • Cognitive behavioral therapy (CBT). First-line for generalized anxiety, panic, social anxiety, and health anxiety; effective in 12 to 16 sessions in most cases.
  • Exposure therapy. Graded exposure for needle phobia and FOH (controlled, supervised experiences of moderate hypoglycemia followed by self-treatment).
  • Mindfulness-based stress reduction (MBSR). Reduces general anxiety; modest benefits on A1C.
  • Acceptance and commitment therapy (ACT). Useful when avoidance behaviors are prominent.

Medications

Medication Class Diabetes Considerations
Escitalopram SSRI Weight-neutral; first-line for GAD and panic
Sertraline SSRI Weight-neutral; well-studied in diabetes
Duloxetine SNRI Helps with neuropathic pain plus anxiety
Buspirone 5-HT1A partial agonist No metabolic side effects; useful add-on
Propranolol Beta-blocker Performance anxiety; may mask hypoglycemia warning signs
Benzodiazepines GABA-A modulators Short-term only; fall and dependence risk

Technology That Reduces Anxiety

  • Continuous glucose monitoring (CGM). Trend arrows, predictive low alerts, and overnight data reduce both fear of hypoglycemia and total hypoglycemic exposure.
  • Automated insulin delivery systems. Hybrid closed-loop pumps reduce nocturnal lows substantially and address one of the main drivers of FOH.
  • Injection ports and shorter needles. Reduce needle anxiety.

Lifestyle Approaches

  • Regular aerobic exercise is one of the strongest non-pharmacologic anxiolytics — see treatment for general activity guidance
  • Sleep hygiene; treat sleep apnea
  • Limit caffeine, especially after early afternoon
  • Limit alcohol — short-term anxiolytic but worsens anxiety and disrupts glucose
  • Diaphragmatic breathing, progressive muscle relaxation, and grounding techniques can interrupt panic episodes
  • Limit news and social media checking patterns that perpetuate worry

When to Seek Urgent Help

  • Panic attacks that recur and limit daily activities
  • Avoidance of insulin or glucose checks because of fear
  • Thoughts of self-harm or suicide
  • Severe agitation, inability to sleep for several nights in a row
  • Acute symptoms with chest pain, breathing difficulty, or fainting — call emergency services to rule out a medical cause

For the broader emotional landscape see diabetes distress and diabetes mood swings. Authoritative references include the ADA 2024 Standards of Care.

The Bottom Line

Anxiety is at least twice as common in diabetes as in the general adult population, with fear of hypoglycemia and needle phobia adding diabetes-specific patterns on top of generalized anxiety. Because hypoglycemia and anxiety look almost identical, anyone on insulin or sulfonylureas should check glucose before treating an episode as panic. CBT, exposure therapy, SSRIs, buspirone, and continuous glucose monitoring address most patterns effectively. Talk to your clinician if anxiety is affecting your daily life, your self-care, or your glucose targets — both conditions improve when treated together.

Frequently Asked Questions

How does anxiety affect blood sugar?

Acute anxiety activates the sympathetic nervous system and releases stress hormones (cortisol, epinephrine), which raise blood glucose. Chronic anxiety also disrupts sleep, increases emotional eating, and reduces motivation for exercise. The opposite is also true — chronic hyperglycemia worsens mood and amplifies anxiety symptoms, creating a feedback loop.

How can I tell a panic attack from low blood sugar?

They feel very similar — tremor, sweating, palpitations, dizziness, nausea, dread. The single most reliable distinction is to check glucose. Anyone on insulin or a sulfonylurea who feels these symptoms should check first and treat hypoglycemia if confirmed; otherwise, use anxiety-management techniques. A continuous glucose monitor can resolve the question instantly and reduce the underlying fear over time.

What is fear of hypoglycemia?

Fear of hypoglycemia (FOH) is a specific anxiety pattern that develops after one or more severe low glucose episodes. People with FOH may keep glucose targets higher than recommended, eat preventive snacks, skip insulin, avoid driving or being alone, or stop exercising. Continuous glucose monitoring, structured exposure to recovery from controlled lows, and CBT all reduce FOH while improving glycemic control.

Are benzodiazepines safe for someone with diabetes?

Short-term, occasional use of benzodiazepines for acute anxiety is sometimes appropriate, but long-term daily use is usually avoided. Concerns include tolerance, dependence, falls and fractures (especially with neuropathy or autonomic dysfunction), cognitive effects in older adults, and interactions with other medications. SSRIs, buspirone, CBT, and lifestyle approaches are preferred for chronic anxiety.

Sources

  1. American Diabetes Association. Standards of Care in Diabetes 2024 (Section 5).
  2. Smith KJ et al. Prevalence of anxiety in diabetes. J Psychosom Res.
  3. Wild D et al. A critical review of the literature on fear of hypoglycemia. Patient Educ Couns.
  4. Spitzer RL et al. A brief measure for assessing generalized anxiety disorder GAD-7. Arch Intern Med.